|
POLR2K expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.65845115418506E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.48197035041176E-13 |
| Normal-vs-Stage2 |
7.60870000338087E-08 |
| Normal-vs-Stage3 |
1.50489953831823E-10 |
| Normal-vs-Stage4 |
1.82139969773232E-10 |
| Stage1-vs-Stage2 |
7.113600E-01 |
| Stage1-vs-Stage3 |
4.210600E-01 |
| Stage1-vs-Stage4 |
5.488100E-02 |
| Stage2-vs-Stage3 |
8.459200E-01 |
| Stage2-vs-Stage4 |
2.743000E-01 |
| Stage3-vs-Stage4 |
2.818000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.96509475358653E-14 |
| Normal-vs-AfricanAmerican |
1.030160E-04 |
| Normal-vs-Asian |
4.76220000100724E-08 |
| Caucasian-vs-AfricanAmerican |
3.627000E-01 |
| Caucasian-vs-Asian |
5.455000E-01 |
| AfricanAmerican-vs-Asian |
6.773200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.50990331349021E-14 |
| Normal-vs-Female |
5.57953683255619E-12 |
| Male-vs-Female |
3.169900E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.02959871131725E-12 |
| Normal-vs-Age(41-60Yrs) |
9.39015531997711E-12 |
| Normal-vs-Age(61-80Yrs) |
1.45720002731053E-09 |
| Normal-vs-Age(81-100Yrs) |
6.972200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.241200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.642400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.024570E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.205400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.419200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.212000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.145200E-01 |
| Classical-VS-Follicular |
1.958970E-01 |
| Classical-VS-Other |
3.323600E-01 |
| Classical-VS-Normal |
1.63391522534084E-12 |
| Tall-VS-Follicular |
1.527050E-01 |
| Tall-VS-Other |
5.502600E-01 |
| Tall-VS-Normal |
9.59729999916448E-08 |
| Follicular-VS-Other |
2.726200E-01 |
| Follicular-VS-Normal |
1.6891799999974E-05 |
| Other-VS-Normal |
3.154400E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.02230454604546E-11 |
| Normal-vs-N1 |
1.34140000218608E-08 |
| N0-vs-N1 |
6.408200E-01 |
|
|
